{"id":8753,"date":"2021-12-17T03:03:22","date_gmt":"2021-12-17T08:03:22","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/puya-supply-eptifibatide-cas-188627-80-7-estaa-verihiutaleiden-aggregaatiota-ja-tromboosia\/"},"modified":"2021-12-17T03:03:22","modified_gmt":"2021-12-17T08:03:22","slug":"puya-supply-eptifibatide-cas-188627-80-7-estaa-verihiutaleiden-aggregaatiota-ja-tromboosia","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fi\/product\/puya-supply-eptifibatide-cas-188627-80-7-estaa-verihiutaleiden-aggregaatiota-ja-tromboosia\/","title":{"rendered":"Puya Supply Eptifibatide CAS 188627-80-7 Est\u00e4\u00e4 verihiutaleiden aggregaatiota ja tromboosia"},"content":{"rendered":"<h2><strong>Puya Supply Eptifibatide CAS 188627-80-7 Est\u00e4\u00e4 verihiutaleiden aggregaatiota ja tromboosia<\/strong><\/h2>\n<p>Tuotteen nimi: Eptifibatidi<br \/>\nSynonyymit: Eptifibatidiasetaattisuola; Eptifibatidi,MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2,MPAHARGDWPC-NH2, &gt;99%;MAP-LYS-GLY-ASP- TRP-PRO-CYS-NH2; INTEGRELIN; Eptifibatidi; N6-(aminoiminometyyli)-N2-(3-merkapto-1-oksopropyyli-L-lysyyliglysyyli-La-aspartyyli-L-tryptofyyli-L-prolyyli-L-kysteiiniamidi;MPA -HAR-GLY-ASP-TRP-PRO-CYS-NH2 (DISULFIDISILTA, MPA1-CYS6); Intrifiban<br \/>\nCAS: 188627-80-7<br \/>\nMF: C35H49N11O9S2<br \/>\nMW: 831,96<br \/>\nEINECS : 641-366-7<br \/>\nTuoteluokat: V\u00e4lituotteet ja hienokemikaalit; peptidit; l\u00e4\u00e4kkeet<br \/>\nMol File: 188627-80-7.mol<\/p>\n<p>Eptifibatidi on er\u00e4\u00e4nlainen synteettinen syklinen heksa6-peptidi, joka koostuu aminohappoja ja 1 merkaptopropionyylit\u00e4hde. Se pystyy sitoutumaan ihmisen verihiutaleiden verihiutaleiden reseptoriglykoproteiiniin (GP) IIb\/IIIa ja est\u00e4m\u00e4\u00e4n verihiutaleiden aggregaatiota ja siten est\u00e4m\u00e4\u00e4n fibrinogeenin, von Willebrand -tekij\u00e4n ja muiden tarttuvien ligandien sitoutumisen. tarkoitettu akuutin sepelvaltimon oireyhtym\u00e4n (ACS) ja perkutaanisen sepelvaltimotaudin hoitoon nintervention (PCI). Se pystyy v\u00e4hent\u00e4m\u00e4\u00e4n akuuttien syd\u00e4men iskeemisten tapahtumien riski\u00e4 potilailla, joilla on ep\u00e4stabiili angina pectoris tai syd\u00e4nlihasinfektio, jolla ei ole ST-segmentin nousua. Sit\u00e4 k\u00e4ytet\u00e4\u00e4n usein yhdess\u00e4 aspiriinin tai klopidogreelin ja hepariinin kanssa. Se voidaan valmistaa liuosfaasipeptidisynteesill\u00e4, ja se voidaan puhdistaa preparatiivisella k\u00e4\u00e4nteisfaasinestekromatografialla ja lyofilisoinnilla. <\/p>\n<p> <strong>Eptifibatidi CAS 188627-80-7 Kemialliset ominaisuudet<\/strong><br \/>\ntiheys 1,60\u00b10,1 g\/cm3 (ennustettu)<br \/>\nvarastointil\u00e4mp\u00f6tila. Suljettu kuivassa,varastoi pakastimessa, alle -20\u00b0C<br \/>\npka 4.01\u00b10.10(ennustettu)<br \/>\nCAS-tietokannan viite 188627-80-7<\/p>\n<p> <strong>Eptifibatidin CAS 188627-80- toiminta ja k\u00e4ytt\u00f6 7<\/strong><br \/>\nArginiini-glysiini-aspartaattia j\u00e4ljittelev\u00e4 aine, joka sitoutuu palautuvasti verihiutaleisiin v\u00e4hent\u00e4\u00e4kseen syd\u00e4men iskeemisten tapahtumien riski\u00e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tuotenimi: Eptifibatide<br \/>\nCAS: 188627-80-7<br \/>\nMF: C35H49N11O9S2<br \/>\nMW: 831.96<br \/>\nEINECS: 641-366-7<br \/>\nMol Tiedosto: 188627-80-7.mol<\/p>\n","protected":false},"featured_media":2100,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[406],"product_tag":[983],"class_list":{"0":"post-8753","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-veren-ja-verisuonten-peptidi","7":"product_tag-puya-supply-eptifibatide-cas-188627-80-7-fi","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product\/8753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/comments?post=8753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media\/2100"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media?parent=8753"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_brand?post=8753"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_cat?post=8753"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_tag?post=8753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}